Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study.
Ross H, Pflugfelder P, Haddad H, Cantarovich M, White M, Ignaszewski A, Howlett J, Vaillancourt M, Dorent R, Burton JR; CADENCE Study Group (CAnadian Pilot Sutdy to Determine Safe and Effective Dosing of Neoral and CErtican in Stable Cardiac Transplant Recipients).
Ross H, et al.
Transpl Int. 2010 Jan;23(1):31-7. doi: 10.1111/j.1432-2277.2009.00940.x.
Transpl Int. 2010.
PMID: 20050127
Free article.
Clinical Trial.